Rosalind Advisors, Inc.
CIK 1622627 · View on SEC EDGAR ↗
- Portfolio value
- $269.2M
- Positions
- 35
- As of
- June 30, 2026
#5,502 of 9,443 by 13F value · top 58.3%
Portfolio value QoQ: +8.2% 13F does not disclose cash
- Top 10 holdings weight
- 74.04%
- Top 25 holdings weight
- 98.07%
- Positions above 1%
- 21
- Effective number of positions
- 13.7
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 9.73% Est. buys $25,197,576 · sells $37,552,312
Median holding: 2.0 quarters Tracked Q4 2024–Q2 2026 · 36.8% still held
- New positions
- 9
- Increased
- 7
- Decreased
- 11
- Closed
- 6
Put-notional exposure: 0.9% puts 13F reports option positions at underlying notional value — may include hedges, not necessarily bearish bets
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- High-conviction bets The holdings this manager is most concentrated in.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
- Related The person behind this filer, where we can match one.
Performance vs S&P 500
Annualized: +8.1% · S&P 500: +17.7%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 95.5% · Options excluded: 3.0%
Sector breakdown
Healthcare
90.7%
Other/Unmapped
9.3%
Full portfolio 35 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| DCTH Delcath Systems, Inc. - Common Stock | $41,551,898 | 15.44% | 3,300,389 | $10,924,288 | |||
| FENC Fennec Pharmaceuticals Inc. - Common Stock | $34,271,011 | 12.73% | 3,188,001 | $16,385,575 | Up ×6 | ||
| XERS Xeris Biopharma Holdings, Inc. - Common Stock | $23,039,130 | 8.56% | 2,908,981 | $4,295,270 | Down ×1 | ||
| SVRA Savara, Inc. - Common Stock | $19,577,225 | 7.27% | 3,178,121 | $2,084,908 | Down ×3 | ||
| VSTM Verastem, Inc. - Common Stock | $15,228,464 | 5.66% | 3,986,509 | $3,894,546 | Up ×2 | ||
| XFOR X4 Pharmaceuticals, Inc. - Common Stock | $15,012,957 | 5.58% | 3,214,766 | $1,735,973 | |||
| EYPT EyePoint, Inc. - Common Stock | $14,131,689 | 5.25% | 988,230 | $768,149 | Down ×1 | ||
| HELP Cybin Inc. - Common Stock | $12,934,541 | 4.80% | 1,956,814 | $5,581,834 | Up ×1 | ||
| VOR Vor Biopharma Inc. - Common Stock | $11,940,726 | 4.44% | 648,600 | $-547,274 | Down ×1 | ||
| PCVX Vaxcyte, Inc. - Common Stock | $11,626,000 | 4.32% | 200,000 | $-5,225,900 | Down ×1 | ||
| MDWD MediWound Ltd. - Ordinary Shares | $11,011,094 | 4.09% | 749,054 | $-1,056,166 | |||
| CLDX Celldex Therapeutics, Inc. - Common Stock | $7,442,000 | 2.76% | 200,000 | $-3,025,600 | Down ×1 | ||
| BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | $7,215,040 | 2.68% | 721,504 | $-1,572,463 | Down ×1 | ||
| PROF Profound Medical Corp. - common stock | $5,506,985 | 2.05% | 828,118 | $140,780 | |||
| TLPH Talphera, Inc. - Common Stock | $5,324,586 | 1.98% | 5,169,501 | $2,819,546 | Up ×1 | ||
| AVIR Atea Pharmaceuticals, Inc. - common stock | $4,978,058 | 1.85% | 1,070,550 | $-1,326,522 | Down ×1 | ||
| MYO | $3,783,401 | 1.41% | 3,637,886 | $1,184,184 | Down ×1 | ||
| OVID Ovid Therapeutics Inc. - Common Stock | $2,980,504 | 1.11% | 1,107,994 | $520,757 | |||
| NRXS | $2,971,106 | 1.10% | 508,055 | $1,277,169 | Up ×1 | ||
| ABVX Abivax SA - American Depositary Shares | $2,781,003 | 1.03% | 20,869 | Up ×1 | |||
| NSPR InspireMD Inc. - Common Stock | $2,734,411 | 1.02% | 3,905,743 | $-3,631,950 | |||
| RGNT | $2,476,948 | 0.92% | 701,685 | $1,708,585 | Up ×1 | ||
| Unknown issuer (CUSIP: 81642T959) | $2,302,500 | 0.86% | 568,700 | Put option | Up ×1 | ||
| PYPD PolyPid Ltd. - Ordinary Shares | $1,978,431 | 0.73% | 389,455 | $-640,485 | Down ×5 | ||
| BFRI Biofrontera Inc. - Common Stock | $1,206,088 | 0.45% | 1,275,609 | $264,443 | Up ×2 | ||
| KURA Kura Oncology, Inc. - Common Stock | $1,097,000 | 0.41% | 100,000 | $284,000 | |||
| SPRB Spruce Biosciences, Inc. - Common Stock | $1,080,000 | 0.40% | 20,000 | Up ×1 | |||
| AQST Aquestive Therapeutics, Inc. - Common Stock | $1,040,000 | 0.39% | 250,000 | $2,500 | |||
| OKUR OnKure Therapeutics, Inc. - Class A Common Stock | $684,000 | 0.25% | 150,000 | $-1,153,179 | Down ×2 | ||
| PEPG PepGen Inc. - Common Stock | $630,000 | 0.23% | 350,000 | Up ×1 | |||
| Unknown issuer (CUSIP: 156944900) | $375,100 | 0.14% | 31,000 | Call option | Up ×1 | ||
| Unknown issuer (CUSIP: 30233G909) | $130,780 | 0.05% | 50,300 | Call option | Up ×1 | ||
| Unknown issuer (CUSIP: 464287955) | $110,000 | 0.04% | 500,000 | Put option | |||
| Unknown issuer (CUSIP: 78464A950) | $35,150 | 0.01% | 140,600 | Put option | |||
| Unknown issuer (CUSIP: 88032L955) | $13,950 | 0.01% | 6,200 | Put option | Up ×1 | ||
| No matches | |||||||
Conviction holdings
Positions increased for 3+ consecutive quarters.
Share counts are as reported in 13F filings (not split-adjusted)
| Security | Value | % of portfolio | Streak |
|---|---|---|---|
| FENC | $34,271,011 | 12.73% | up ×6 |
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| ABVX | $2,781,003 | 20,869 | 1.03% |
| Unknown issuer (CUSIP: 81642T959) | $2,302,500 | 568,700 | 0.86% |
| SPRB | $1,080,000 | 20,000 | 0.40% |
| PEPG | $630,000 | 350,000 | 0.23% |
| Unknown issuer (CUSIP: 156944900) | $375,100 | 31,000 | 0.14% |
| Unknown issuer (CUSIP: 30233G909) | $130,780 | 50,300 | 0.05% |
| Unknown issuer (CUSIP: 464287955) | $110,000 | 500,000 | 0.04% |
| Unknown issuer (CUSIP: 78464A950) | $35,150 | 140,600 | 0.01% |
| Unknown issuer (CUSIP: 88032L955) | $13,950 | 6,200 | 0.01% |
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| FENC | Bought more | +280K | +$16.4M |
| DCTH | Price move only | +0 | +$10.9M |
| HELP | Bought more | +425K | +$5.6M |
| PCVX | Trimmed | -90K | -$5.2M |
| XERS | Trimmed | -323K | +$4.3M |
| VSTM | Bought more | +1.8M | +$3.9M |
| NSPR | Price move only | +0 | -$3.6M |
| CLDX | Trimmed | -130K | -$3.0M |
| TLPH | Bought more | +1.8M | +$2.8M |
| SVRA | Trimmed | -26K | +$2.1M |
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| RZLT | Dec. 31, 2025 | 1,807,202 | $16,987,698 | 107.8% |
| REPL | March 31, 2026 | 1,410,497 | $13,710,031 | 91.2% |
| ATYR | March 31, 2026 | 1,039,080 | $13,601,557 | -33.4% |
| CYTK | March 31, 2026 | 195,045 | $12,393,159 | 17.5% |
| VRNA | Dec. 31, 2025 | 100,000 | $10,671,000 | No longer tracked |
| CMRX | March 31, 2025 | 3,050,000 | $10,614,000 | No longer tracked |
| MNMD | March 31, 2026 | 750,000 | $10,042,500 | No longer tracked |
| IDYA | Dec. 31, 2025 | 350,000 | $9,523,500 | 17.3% |
| ABEO | June 30, 2025 | 1,805,817 | $8,595,689 | 7.6% |
| REPL | Sept. 30, 2025 | 900,000 | $8,361,000 | 249.0% |
| URGN | Sept. 30, 2025 | 542,366 | $7,430,414 | 131.9% |
| QURE | Dec. 31, 2025 | 125,000 | $7,296,250 | 106.6% |
| CGON | June 30, 2026 | 100,000 | $6,768,000 | 10.1% |
| VRDN | June 30, 2026 | 250,401 | $4,897,844 | 34.0% |
| OCUL | March 31, 2026 | 400,000 | $4,856,000 | 33.1% |
| AVBP | March 31, 2026 | 215,871 | $4,343,325 | 27.3% |
| NUVB | June 30, 2025 | 2,451,500 | $4,314,640 | 258.2% |
| PHVS | Sept. 30, 2025 | 223,627 | $3,935,835 | 45.9% |
| DFTX | June 30, 2026 | 125,000 | $2,362,500 | -2.1% |
| OPTN | June 30, 2025 | 256,190 | $2,349,262 | No longer tracked |
| KALV | Sept. 30, 2025 | 157,725 | $1,783,081 | No longer tracked |
| LPCN | June 30, 2026 | 221,616 | $1,770,712 | -18.4% |
| COGT | June 30, 2025 | 248,285 | $1,487,227 | 403.5% |
| CMPS | Sept. 30, 2025 | 482,651 | $1,351,422 | 140.9% |
| TRVI | March 31, 2026 | 100,000 | $1,252,000 | 53.5% |
| AVTX | June 30, 2026 | 75,000 | $1,119,750 | 8.2% |
| ATXS | Dec. 31, 2025 | 1,542,520 | $1,112,773 | No longer tracked |
| ANNX | June 30, 2026 | 200,000 | $1,108,000 | -8.9% |
| SAVA | March 31, 2025 | 417,400 | $985,064 | No longer tracked |
| GUTS | March 31, 2026 | 385,731 | $848,608 | 55.2% |
| KPRX | June 30, 2025 | 250,059 | $752,678 | -9.0% |
| ACOG | June 30, 2025 | 104,836 | $530,470 | 8.0% |
| OWLT | March 31, 2025 | 49,441 | $220,012 | 54.8% |
| OVID | Sept. 30, 2025 | 500,000 | $164,950 | 115.4% |
| RLMD | March 31, 2025 | 100,000 | $52,000 | 1637.0% |